Published in Arch Dermatol on August 01, 1990
"The end of innocence" revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev (1994) 1.54
Varicella-zoster virus disease in patients with human immunodeficiency virus infection. Arch Dermatol (1990) 1.02
Distribution of varicella zoster virus and herpes simplex virus in disseminated fatal infections. J Clin Pathol (1996) 0.87
Approches actuelles au traitement du zona: Aspects controversés du traitement du zona. Can Fam Physician (1992) 0.75
Leg ulcers. J Am Acad Dermatol (1991) 2.74
Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol (2001) 2.33
Treatment of tattoos by Q-switched ruby laser. A dose-response study. Arch Dermatol (1990) 2.01
Selective photothermolysis of cutaneous pigmentation by Q-switched Nd: YAG laser pulses at 1064, 532, and 355 nm. J Invest Dermatol (1989) 1.60
Laser treatment of pigmented lesions--2000: how far have we gone? Arch Dermatol (2000) 1.54
Brief report: graft-versus-host disease associated with transfusion of blood from unrelated HLA-homozygous donors. N Engl J Med (1993) 1.46
Transfusion-associated graft-vs-host disease in patients with malignancies. Report of two cases and review of the literature. Arch Dermatol (1990) 1.42
Facial skin rejuvenation: laser resurfacing or chemical peel: choose your weapon. Dermatol Surg (2001) 1.39
Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg (1999) 1.37
Necrobiosis lipoidica. J Am Acad Dermatol (1991) 1.16
The role of lasers and light sources in the treatment of leg veins. Dermatol Surg (1999) 1.11
Prevalence of skin disease in a cohort of shelter-based homeless men. J Am Acad Dermatol (1999) 1.10
Treatment of minocycline-induced hyperpigmentation with the Q-switched ruby laser. Arch Dermatol (1996) 0.99
Accessibility and reliability of cutaneous laser surgery information on the World Wide Web. J Am Acad Dermatol (2000) 0.98
Disseminated superficial actinic porokeratosis. Coexistence with other porokeratotic variants. Arch Dermatol (1986) 0.93
Release of prostaglandin D2 and histamine in a case of localized heat urticaria, and effect of treatments. Br J Dermatol (1986) 0.92
Serum albumin. Differences in assay specificity. Nutr Clin Pract (1989) 0.91
Birt-Hogg-Dube syndrome: treatment of cutaneous manifestations with laser skin resurfacing. Arch Dermatol (2001) 0.90
Vancomycin-induced linear IgA bullous dermatosis. Arch Dermatol (1988) 0.89
A clinical and histologic prospective controlled comparative study of the picosecond titanium:sapphire (795 nm) laser versus the Q-switched alexandrite (752 nm) laser for removing tattoo pigment. J Am Acad Dermatol (1999) 0.89
Recent advances in dermatology. N Engl J Med (1992) 0.88
Basic laser principles. Dermatol Clin (1997) 0.88
Q-switched ruby laser irradiation of normal human skin. Histologic and ultrastructural findings. Arch Dermatol (1991) 0.87
On beauty: evolution, psychosocial considerations, and surgical enhancement. Arch Dermatol (2001) 0.86
Cutaneous polyarteritis nodosa associated with hepatitis B surface antigen. J Am Acad Dermatol (1986) 0.86
Melanosomes are a primary target of Q-switched ruby laser irradiation in guinea pig skin. J Invest Dermatol (1987) 0.86
Fractional Laser treatment for pigmentation and texture improvement. Skin Therapy Lett (2006) 0.85
Laser therapy versus cryotherapy of lentigines: a comparative trial. J Am Acad Dermatol (1994) 0.85
Sebaceous adenoma in a patient with acquired immunodeficiency syndrome. Arch Dermatol (1988) 0.82
Laser skin resurfacing. Arch Dermatol (1996) 0.81
Pemphigus foliaceus induced by psoralen-UV-A. Arch Dermatol (1998) 0.81
Interaction between cyclosporin and rifampicin. Lancet (1984) 0.81
The use of lasers for decorative tattoo removal. Skin Therapy Lett (2006) 0.81
Lichenoid dermatoses and related disorders. II. Lichen nitidus, lichen sclerosus et atrophicus, benign lichenoid keratoses, lichen aureus, pityriasis lichenoides, and keratosis lichenoides chronica. J Am Acad Dermatol (1990) 0.81
Pancytopenia induced by the interaction between methotrexate and trimethoprim-sulfamethoxazole. J Am Acad Dermatol (1987) 0.81
Evaluation of a silicone occlusive dressing after laser skin resurfacing. Arch Dermatol (2001) 0.81
Autonomic neurodermatology (Part II): Disorders of sweating and flushing. Semin Neurol (1992) 0.80
Treatment of acne scarring. Skin Therapy Lett (2006) 0.80
A clinical overview of hair removal using lasers and light sources. Dermatol Clin (1999) 0.79
Visible action spectrum for melanin-specific selective photothermolysis. Lasers Surg Med (1989) 0.79
The use of lasers in the pediatric population. Skin Therapy Lett (2005) 0.77
Laser treatment of tattoos: a prospective, paired, comparison study of the Q-switched Nd:YAG (1064 nm), frequency-doubled Q-switched Nd:YAG (532 nm), and Q-switched ruby lasers. J Am Acad Dermatol (1997) 0.77
Nonablative laser and light therapy: an approach to patient and device selection. Skin Therapy Lett (2003) 0.77
Kaposi's sarcoma and Mycobacterium avium-intracellulare with cellulitis in patient with acquired immunodeficiency syndrome. J Am Acad Dermatol (1989) 0.76
Pulsed dye laser-resistant port-wine stains. Arch Dermatol (1996) 0.76
Lasers in dermatology--1993. Arch Dermatol (1993) 0.76
Are all 585 nm pulsed dye lasers equivalent? A prospective, comparative, photometric, and histologic study. J Am Acad Dermatol (1996) 0.75
Successful treatment of eruptive pyoderma gangrenosum with intravenous vancomycin and mezlocillin. Br J Dermatol (1990) 0.75
A reaction to a red lip cosmetic tattoo. J Am Acad Dermatol (1998) 0.75
Spontaneous bullae over laser resurfaced skin. J Am Acad Dermatol (2000) 0.75
[Lasers and aesthetic dermatology]. Hautarzt (2003) 0.75
Autonomic neurodermatology (Part I): Erythromelalgia, reflex sympathetic dystrophy, and livedo reticularis. Semin Neurol (1992) 0.75
Keratinocyte protein expression in rapidly regenerating epidermis following laser-induced thermal injury. Lasers Surg Med (1989) 0.75
Tumorous nodules on the lower extremities. Systemic mastocytosis. Arch Dermatol (1991) 0.75
Aesthetic surgery: coming of age. Lancet (2000) 0.75
Dermatology. JAMA (1990) 0.75
Lasers. J Am Acad Dermatol (1995) 0.75
Lichen planus localized to the nails. J Cutan Med Surg (1998) 0.75
Psoralens. New formulation! Better formulation? Arch Dermatol (1986) 0.75
Lasers for vascular lesions. Dermatol Nurs (1999) 0.75
Recent therapeutic advances in dermatology. JAMA (2000) 0.75
Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions. Br J Dermatol (1995) 0.75
Treatment of photoaging with topical aminolevulinic acid and light. Skin Therapy Lett (2005) 0.75
Advances in cutaneous aesthetic surgery. JAMA (1998) 0.75
Severe hemorrhage from a 4 mm punch biopsy site in a hemophilia patient with acquired immunodeficiency syndrome. J Am Acad Dermatol (1989) 0.75
Use of cutaneous lasers and light sources: appropriate training and delegation. Skin Therapy Lett (2007) 0.75
Eczematous plaques in a patient with liver failure. Fat-soluble vitamin K hypersensitivity. Arch Dermatol (1992) 0.75
Herpes simplex. Semin Neurol (1992) 0.75
Images in clinical medicine. Basal-cell carcinoma. N Engl J Med (1993) 0.75
Ecthymalike lesions on the leg of an immunocompromised patient. Primary cutaneous mucormycosis. Arch Dermatol (1995) 0.75
Cutaneous manifestations of human immunodeficiency virus infection. Semin Neurol (1992) 0.75
Comparison of the 595 nm long-pulse (1.5 msec) and ultralong-pulse (4 msec) lasers in the treatment of leg veins. Dermatol Surg (1999) 0.75
Dermatology. JAMA (1989) 0.75
CO2 laser resurfacing: why all the fuss? Plast Reconstr Surg (1996) 0.75
Linear porokeratosis of Mibelli and DSAP. Clin Exp Dermatol (1986) 0.75
Lichenoid dermatoses and related disorders. I. Lichen planus and lichenoid drug-induced eruptions. J Am Acad Dermatol (1990) 0.75
Malignant pyoderma: a manifestation of Wegener's granulomatosis? J Am Acad Dermatol (1986) 0.75
Recurrent exacerbation of acne by granulocyte colony-stimulating factor administration. J Am Acad Dermatol (1996) 0.75